Caliber utilizes all technological pathways to enable rapid development of safe and effective therapeutics for cancer and infectious diseases. With broad capabilities in plant, cell culture, and microbial-based development systems, Caliber maintains the full range of options for product development to respond to current unmet patient and global needs in therapeutic protein and vaccine development and manufacturing.

Caliber’s development platforms are flexible utilizing equipment with disposable technologies thereby facilitating rapid and cost effective product development programs. The therapies we choose to develop are driven by unmet medical needs and patient impact, rather than just market size. We can address the needs of many with rapid response, high volume vaccine production and few with protein therapeutics for orphan diseases and personalized cancer treatments.

Plant-Made Pharmaceuticals

Modular Bioprocessing Facilities

Oncology Product Development

Analytical Capabilities Partnerships or Sponsored Research